Cerity Partners’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Buy |
41,904
+1,196
| +3% | +$33.1K | ﹤0.01% | 1451 |
|
|
2025
Q1 | $904K | Buy |
40,708
+12,110
| +42% | +$269K | ﹤0.01% | 1471 |
|
|
2024
Q4 | $713K | Sell |
28,598
-4,786
| -14% | -$119K | ﹤0.01% | 1575 |
|
|
2024
Q3 | $834K | Buy |
+33,384
| New | +$834K | ﹤0.01% | 1490 |
|
|
2024
Q2 | – | Sell |
-29,683
| Closed | -$586K | – | 2314 |
|
|
2024
Q1 | $586K | Buy |
+29,683
| New | +$586K | ﹤0.01% | 1528 |
|
|
2021
Q3 | – | Sell |
-25,000
| Closed | -$348K | – | 706 |
|
|
2021
Q2 | $348K | Hold |
25,000
| – | – | 0.01% | 542 |
|
|
2021
Q1 | $463K | Buy |
+25,000
| New | +$463K | 0.01% | 464 |
|